European Study Group on Lysosomal Diseases Virtual Summer Meeting 2021

10 $

‘+ Include: 3 videos + 1 pdf, size: 35.3 GB

+ Target Audience: pathology physician

Categories: , ,


+ Include: 3 videos + 1 pdf, size: 35.3 GB

+ Target Audience: pathology physician

+ Sample video: contact me for sample video

+ Topics:

June 28.mp4
June 29.mp4
June 30.mp4
ESGLD 2021 _ ESGLD.pdf

*** Detail:

Day 1 Thursday 8th September
14:00 – 18:00 Registration
18:00 – 18:15 Opening Ceremony – Welcome Address
18:15 – 18:30 Flash talk awards
18:30 – 19:30 KEYNOTE SPEAKER 1 Professor Simon Jones, Manchester University Hospitals NHS Foundation Trust, UK
19:30 – 20:00 BREAK
20:00 onwards Get together and dinner
Day 2 Tuesday 29th June
Lysosomal Function
Session 1 (Chair Andrea Ballabio)
12pm (BST)/1pm (CEST) Keynote speaker – Juan Bonifacino – NIH, Bethesda, USA Molecular mechanisms of lysosome positioning Bright ideas/flash talks
12.35pm (BST)/1.35pm (CEST) S.L.M. in ‘t Groen – Uncovering pathological mechanisms in Pompe disease using a 3D-skeletal-muscle-on-a-chip system.
12.40pm (BST)/1.40pm (CEST) Mara Reichmann – Loss of TMEM55B leads to subfertility in male mice
12.45pm (BST)/1.45pm (CEST) Florian Bleimbaum – Co-expression network analysis identifies NHLRC3 as a new lysosomal protein to control endothelial cell homeostasis
12.50pm (BST)/1.50pm (CEST) Tereza Andreou – Brain-targeted Haematopoietic Stem Cell Gene Therapy for severe Mucopolysaccharidosis I (Hurler) – does one peptide tag fit all? 12.55pm (BST)/1.55pm (CEST) Jane Potter – Ex-vivo autologous haematopoietic stem cell gene therapy in mucopolysaccharidosis type IIIA
1pm (BST)/2pm (CEST) Q&A group discussion (Chair Andrea Ballabio)
1.20pm (BST)/2.20pm (CEST) Coffee break
Session 2 (Chair Mia Horowitz)
1.40pm (BST)/2.40pm (CEST) Invited speaker – Chiara di Malta – TIGEM, Naples, Italy – Transcriptional regulation of mTORC1 signaling in physiology and cancer
2.15pm (BST)/3.15pm (CEST) M Klussendorf – Cytoplasmic retention of acetylated transcription factor EB

2.35pm (BST)/3.35pm (CEST) Sonke Rudnik – S-palmitoylation determines TMEM55B- dependent positioning of lysosomes

2.55pm (BST)/3.55pm (CEST) Coffee break
Session 3 (Chair Thomas Braulke)
3.15pm (BST)/4.15pm (CEST) Invited speaker – James H. Hurley – University of California, Berkley, USA – Coordination of the Rag GTPase cycle on lysosomes
3.50pm (BST)/4.50pm (CEST) Dominic Winter – Characterization of Lysosomal Protein Interactions and Structures by Cross Linking Mass Spectrometry
4.10pm (BST)/5.10pm (CEST) Shroddha Bose – Impact of altered chloride transport on lysosomal morphology and function
4.30pm (BST)/5.30pm (CEST) Group discussion on lysosomal function (Chaired by Andrea Ballabio and Including Invited speakers from the day)
5.00pm (BST)/6.00pm (CEST) Day 2 main conference closes
5 – 5.30pm (BST)/6 – 6.30pm (CEST) Day 2 – Zoom Drinks Reception (Everyone Welcome – Bring Your Own Beer!) Meeting ID will follow
Day 3 Wednesday 30th June
Therapies and diagnosis
Session 1 (Chair Francisca Coutinho)
12pm (BST)/1pm (CEST) Invited speaker – Sandra Alves – Instituto Nacional de Saúde Dr. Ricardo Jorge (INSA), Portugal – Oligonucleotide-based therapies for inherited metabolic diseases: some examples of their application in Lysosomal Storage Disorders.
12.35pm (BST)/1.35pm (CEST) Xuefang Pan – Oral Glucosamine Ameliorates Aggravated Neurological Phenotype in Mucopolysaccharidosis III Type C Mouse Model Expressing Misfolded HGSNAT Variant
12.55pm (BST)/1.55pm (CEST) Atze Bergsma – Identification of aberrant splicing events that induce nonsense-mediated decay and development of splice switching antisense oligonucleotides for Pompe disease
1.15pm (BST)/2.15pm (CEST) Coffee break

Session 2 (Chair Pim Pijnappel)
1.35pm (BST)/2.35pm (CEST) Invited speaker – Federico Mingozzi – Spark Therapeutics, Philadelphia, USA – Targeting the liver to develop in vivo gene therapies for lysosomal storage diseases
2.10pm (BST)/3.10pm (CEST) Alessandro di Spiezio – Enzyme replacement therapy with pro cathepsin D in NCL disease
2.30pm (BST)/3.30pm (CEST) Valeria De Pasquale – Targeting heparin sulfate proteoglycans as a novel treatment for neuropathology in Mucopolysaccharidosis IIIB
2.50pm (BST)/3.50pm (CEST) Coffee break
Session 3 (Chair Brian Bigger)
3.10pm (BST)/4.10pm (CEST) Invited speaker – Eric Adler – UC San Diego, La Jolla, USA- New Therapy for Danon Disease (TBC)

3.45pm (BST)/4.45pm (CEST) Shaun Wood – Long-term Outcomes of Brain-targeted Haematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis Type II in Pre-Clinical MPSII Mouse Model

4.05pm (BST)/5.05pm (CEST) Nicola Brunetti – Safety and efficacy of liver-directed AAV-mediated gene therapy for mucopolysaccharidosis type VI

4.25pm (BST)/5.25pm (CEST) Group discussion on therapies and diagnosis (Chaired by Brian Bigger and Including Invited speakers from the day)
4.45pm (BST)/5.45pm (CEST) Coffee break
4.55pm (BST)/5.55pm (CEST) Award for best presentation
5pm(BST)/6pm (CEST) Award for best flash talk
5.05pm (BST)/6.05pm (CEST) Concluding remarks
5.10pm (BST)/6.10pm (CEST) Conference close


There are no reviews yet.

Be the first to review “European Study Group on Lysosomal Diseases Virtual Summer Meeting 2021”

Your email address will not be published. Required fields are marked *